Treatment Of Magnesium-L-Threonate Elevates The Magnesium Level In The Cerebrospinal Fluid And Attenuates Motor Deficits And Dopamine Neuron Loss In A Mouse Model Of Parkinson’s disease

PURPOSE: Epidemiology research has demonstrated that magnesium (Mg) deficiency is associated with a high incidence of Parkinson’s disease (PD). It is known that the systemic administration of MgSO(4) is not able to elevate the Mg concentration in cerebrospinal fluid (CSF). This study aims to verify...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Yanling, Dai, Ling, Tian, Haibo, Xu, Runnan, Li, Fuying, Li, Zhuohang, Zhou, Jeremy, Wang, Liping, Dong, Jianghui, Sun, Liyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6857673/
https://www.ncbi.nlm.nih.gov/pubmed/31806980
http://dx.doi.org/10.2147/NDT.S230688

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6857673/
https://www.ncbi.nlm.nih.gov/pubmed/31806980
http://dx.doi.org/10.2147/NDT.S230688

Ejemplares similares